Related Experiment Videos
Inducible carboxypeptidase activity in vancomycin-resistant enterococci.
L Gutmann1, D Billot-Klein, S al-Obeid
1Laboratoire de Microbiologie Médicale, Université Paris VI, France.
Antimicrobial Agents and Chemotherapy
|January 1, 1992
Summary
Vancomycin coinduces DD-carboxypeptidase activity and resistance in enterococci. This enzyme
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Enterococci exhibit resistance to glycopeptide antibiotics like vancomycin.
- The mechanisms underlying vancomycin resistance in enterococci are not fully elucidated.
- DD-carboxypeptidase activity has been implicated in bacterial cell wall metabolism.
Purpose of the Study:
- To investigate the role of DD-carboxypeptidase activity in vancomycin resistance in enterococci.
- To determine if vancomycin can induce DD-carboxypeptidase activity.
- To characterize the enzymatic properties of the induced DD-carboxypeptidase.
Main Methods:
- Testing eight strains of enterococci for vancomycin-induced resistance and DD-carboxypeptidase activity.
- Analyzing a constitutively resistant mutant (MT10) of Enterococcus faecium (D366).
- In vitro enzymatic assays using various substrates and inhibitors.
Main Results:
- Vancomycin coinduced DD-carboxypeptidase activity and resistance in susceptible enterococcal strains.
- A resistant mutant (MT10) exhibited spontaneous carboxypeptidase activity.
- The enzyme utilized pentapeptide, UDP-MurNac-pentapeptide, and D-alanyl-D-alanine as substrates and was penicillin-insensitive.
- A correlation was observed between vancomycin resistance levels and carboxypeptidase activity.
Conclusions:
- DD-carboxypeptidase is a key component of the vancomycin resistance mechanism in enterococci.
- The enzyme's activity is linked to the modification of peptidoglycan precursors.
- Understanding this mechanism could inform strategies to combat antibiotic resistance.